BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31159827)

  • 1. Molecular profiling of microinvasive breast cancer microenvironment progression.
    Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
    J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of the tumor microenvironment during breast cancer progression.
    Ma XJ; Dahiya S; Richardson E; Erlander M; Sgroi DC
    Breast Cancer Res; 2009; 11(1):R7. PubMed ID: 19187537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
    Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
    Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
    Schedin P; Borges V
    Breast Cancer Res; 2009; 11(2):102. PubMed ID: 19344495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
    Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
    Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
    Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
    Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.
    Smith L; Baxter EW; Chambers PA; Green CA; Hanby AM; Hughes TA; Nash CE; Millican-Slater RA; Stead LF; Verghese ET; Speirs V
    PLoS One; 2015; 10(10):e0139698. PubMed ID: 26437339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genomic ruler to assess oncogenic transition between breast tumor and stroma.
    Dhage S; Ernlund A; Ruggles K; Axelrod D; Berman R; Roses D; Schneider RJ
    PLoS One; 2018; 13(10):e0205602. PubMed ID: 30325954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
    Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
    BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma.
    Risom T; Glass DR; Averbukh I; Liu CC; Baranski A; Kagel A; McCaffrey EF; Greenwald NF; Rivero-Gutiérrez B; Strand SH; Varma S; Kong A; Keren L; Srivastava S; Zhu C; Khair Z; Veis DJ; Deschryver K; Vennam S; Maley C; Hwang ES; Marks JR; Bendall SC; Colditz GA; West RB; Angelo M
    Cell; 2022 Jan; 185(2):299-310.e18. PubMed ID: 35063072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.
    Lesurf R; Aure MR; Mørk HH; Vitelli V; ; Lundgren S; Børresen-Dale AL; Kristensen V; Wärnberg F; Hallett M; Sørlie T
    Cell Rep; 2016 Jul; 16(4):1166-1179. PubMed ID: 27396337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced Stromal STAT1 Accelerates Breast Cancer via Deregulating Tissue Homeostasis.
    Zellmer VR; Schnepp PM; Fracci SL; Tan X; Howe EN; Zhang S
    Mol Cancer Res; 2017 May; 15(5):585-597. PubMed ID: 28108623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
    Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
    Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stromal gene signature associated with inflammatory breast cancer.
    Boersma BJ; Reimers M; Yi M; Ludwig JA; Luke BT; Stephens RM; Yfantis HG; Lee DH; Weinstein JN; Ambs S
    Int J Cancer; 2008 Mar; 122(6):1324-32. PubMed ID: 17999412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.
    Witkiewicz AK; Kline J; Queenan M; Brody JR; Tsirigos A; Bilal E; Pavlides S; Ertel A; Sotgia F; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1794-809. PubMed ID: 21521946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.